Aptus Pharma Limited – IPO
Aptus Pharma Limited – IPO Details
| IPO Date | September 23, 2025 to September 25, 2025 |
| Listing Date | September 30, 2025 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 65 to ₹ 70 / Share |
| Lot Size | 2000 Shares |
| Total Issue Size | 18,60,000 shares (Aggregating up to ₹13.02 Cr) |
| Fresh Issue | |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share holding pre issue | 50,00,000 shares |
| Share holding post issue | 68,60,000 shares |
| Market Maker portion |
Aptus Pharma Limited Timeline (Tentative Schedule)
Aptus Pharma Limited IPO opens on September 23, 2025, and closes on September 25, 2025.
| IPO Open Date | September 23, 2025 |
| IPO Close Date | September 25, 2025 |
| Basis of Allotment | September 26, 2025 |
| Initiation of Refunds | September 29, 2025 |
| Credit of Shares to Demat | September 29, 2025 |
| Listing Date | September 30, 2025 |
| Cut-off time for UPI mandate confirmation | September 25, 2025 |
Aptus Pharma Limited IPO Lot Size
Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | Rs.280,000 |
| Retail (Max) | 2 | 4,000 | Rs.280,000 |
| S-HNI (Min) | 3 | 6,000 | Rs.420,000 |
| S-HNI (Max) | 7 | 14,000 | Rs.980,000 |
| B-HNI (Min) | 8 | 16,000 | Rs.1,120,000 |
| HNI (Min) |
Aptus Pharma Limited IPO Promoter Holding
| Share Holding Pre Issue | 100% |
| Share Holding Post Issue | 72.89% |
Aptus Pharma Limited IPO Reservation
Aptus Pharma IPO offers a total of 18,60,000 shares. Out of which 8,80,000 (47.31%) allocated to QIB, 3,52,000 (18.92%) allocated to QIB (Ex- Anchor), 2,66,000 (14.30%) allocated to NII, 6,20,000 (33.33%) allocated to RII, and 5,28,000 (28.39%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | 94,000 (5.05%) |
|
| Other Shares Offered | |
|
| QIB Shares Offered | 8,80,000 (47.31%) |
|
| NII (HNI) Shares Offered | 2,66,000 (14.30%) |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | 6,20,000 (33.33%) |
|
| Employee Shares Offered | |
|
| Total Shares Offered | 18,60,000 (100.00%) |
Aptus Pharma Limited IPO Anchor Investors Details
Aptus Pharma IPO raises ₹3.70 crore from anchor investors. Aptus Pharma IPO Anchor bid date is September 22, 2025.
| Bid Date | 2025-09-22 |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | 3.70 |
| Anchor lock-in period end date for 50% shares (30 Days) | October 26, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | December 25, 2025 |
About Aptus Pharma Limited
Incorporated in the year 2010, Aptus Pharma Ltd is in the business of marketing and distribution of finished pharmaceutical formulations
The company is manufacturer and distributors of a wide range of pharmaceutical formulations covering various therapeutic areas: antacids & PPIs, pain, anti-inflammatory, anti-biotics, cardiology & anti-diabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, etc.
Products:
Aptus Pharma: Deals with acute therapies i.e, anti-infectives, pain management, etc.
Aptus CD care: Was dealing with chronic therapies
Aptus Wellcare: Distribution of wellness and nutraceutical products
Aptus Global: Export in foreign market
As of March 31, 2025, the company has 194 pharmaceutical formulations in over eleven therapeutic segments.
Its warehouse is based over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution network consists of 125 direct and sub distributors and a sales force of 54 field staff.
As of March 31, 2025, the company employed 70 people.
Competitive Strengths
Diversified product range
Strong distribution base
Strategic manufacturing alliances in Gujarat, Uttarakhand and Himachal Pradesh
Competitively priced and cost-effective
Strong management team
Key Performance Indicator
The market capitalization of Aptus Pharma IPO is ₹48.02 Cr.
| KPI | Values |
|---|---|
| ROE | 44.50% |
| ROCE | 45.66% |
| Debt/Equity | 1.49 |
| RoNW | 44.50% |
| P/BV | |
| PAT Margin (%) |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 6.20 | 4.52 |
| P/E (x) | 11.29 | 15.49 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of March 31, 2025, which is available in RHP.
Objects of the Issue (Aptus Pharma Limited IPO Objectives)
Aptus Pharma Limited Contact Details
Aptus Pharma Ltd. Ashutosh Buildcon, Opp. Slok - 2, Nr. Harikrupa Logistic Park, Aslali, Ahmedabad, Daskroi, Ahmedabad, Gujarat, 382427 Phone: +91 76004 27827 Email: [email protected] Website: https://aptus-pharma.com/ |
Aptus Pharma Limited IPO Registrar
Bigshare Services Pvt.Ltd. Phone: +91-22-6263 8200 Email: [email protected] |